Delivery Order SPE2DB25D9348-SPE2DB25FNMWE
- Not listed
- The Defense Logistics Agency awarded a $14.9 million delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. Issued on June 18, 2025, with an ultimate completion date of July 11, 2025, this firm fixed-price delivery order carries no set-aside designation. The award is structured as a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $14,910.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6ml units. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a discrete task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company...
- The Defense Logistics Agency awarded a delivery order valued at $22,365.06 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at approximately $22.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6 milliliter units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This award represents a direct fulfillment transaction under DMS...
- The Defense Logistics Agency (DLA) awarded a $7,455.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit in 6ml quantities. The contract is valued at $14,910.04 under a firm fixed-price arrangement with an ultimate completion date of June 25, 2025. This delivery order was issued without set-aside designation and represents a continuation of DMS Pharmaceutical Group's significant role...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- The Defense Logistics Agency has awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Photrexa Cross-Linking Kit 6ml. This delivery order, issued on August 22, 2025, carries a firm fixed price and an ultimate completion date of September 15, 2025. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the...
- The Defense Logistics Agency awarded a $18,637.55 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The company will perform this delivery order at its Park Ridge, IL location, continuing its...
- The Defense Logistics Agency awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-linking Kit in 6ML quantities. This delivery order is issued under the firm fixed-price contract type with an ultimate completion date of September 29, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted...
- SPE2DB25D9348Indefinite Delivery Contract
- SPE2DB25D9348-SPE2DB25FNMWEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,727.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-linking Kit 6ML. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries no set-aside designation, allowing the vendor to compete on the open market while leveraging its woman-owned small business status. Photrexa is a specialized pharmaceutical product used in corneal cross-linking procedures, reflecting the DLA's broad procurement mission to supply medical and pharmaceutical products to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's award under this delivery order underscores its established position as a critical supplier within the federal pharmaceutical supply chain. The company maintains a $500 million SPE2DB Indefinite Delivery Contract with the DLA through November 2026, which serves as the contracting vehicle for this transaction and enables the issuance of multiple firm fixed-price delivery orders for an extensive portfolio of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables. This delivery order for Photrexa exemplifies the routine pharmaceutical resupply operations supporting military health facilities, demonstrating DMS Pharmaceutical Group's capability to fulfill specialized medical product requirements across the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/26/25 |